81 related articles for article (PubMed ID: 22065223)
1. Determination of kinase inhibitor potencies in cell extracts by competition binding assays and isobaric mass tags.
Hopf C; Eberhard D; Boesche M; Bastuck S; Dümpelfeld B; Bantscheff M
Methods Mol Biol; 2012; 803():141-55. PubMed ID: 22065223
[TBL] [Abstract][Full Text] [Related]
2. Kinase inhibitor profiling using chemoproteomics.
Schirle M; Petrella EC; Brittain SM; Schwalb D; Harrington E; Cornella-Taracido I; Tallarico JA
Methods Mol Biol; 2012; 795():161-77. PubMed ID: 21960222
[TBL] [Abstract][Full Text] [Related]
3. Proteome-wide identification of staurosporine-binding kinases using capture compound mass spectrometry.
Fischer JJ; Graebner Neé Baessler OY; Dreger M
Methods Mol Biol; 2012; 795():135-47. PubMed ID: 21960220
[TBL] [Abstract][Full Text] [Related]
4. Affinity classification of kinase inhibitors by mass spectrometric methods and validation using standard IC(50) measurements.
Jecklin MC; Touboul D; Jain R; Toole EN; Tallarico J; Drueckes P; Ramage P; Zenobi R
Anal Chem; 2009 Jan; 81(1):408-19. PubMed ID: 19067573
[TBL] [Abstract][Full Text] [Related]
5. Identification of cellular MMP substrates using quantitative proteomics: isotope-coded affinity tags (ICAT) and isobaric tags for relative and absolute quantification (iTRAQ).
Butler GS; Dean RA; Morrison CJ; Overall CM
Methods Mol Biol; 2010; 622():451-70. PubMed ID: 20135298
[TBL] [Abstract][Full Text] [Related]
6. Chemoproteomic characterization of protein kinase inhibitors using immobilized ATP.
Duncan JS; Haystead TA; Litchfield DW
Methods Mol Biol; 2012; 795():119-34. PubMed ID: 21960219
[TBL] [Abstract][Full Text] [Related]
7. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
[TBL] [Abstract][Full Text] [Related]
8. Probing the specificity of protein-protein interactions by quantitative chemical proteomics.
Kovanich D; Aye TT; Heck AJ; Scholten A
Methods Mol Biol; 2012; 803():167-81. PubMed ID: 22065225
[TBL] [Abstract][Full Text] [Related]
9. Enrichment and analysis of peptide subsets using fluorous affinity tags and mass spectrometry.
Brittain SM; Ficarro SB; Brock A; Peters EC
Nat Biotechnol; 2005 Apr; 23(4):463-8. PubMed ID: 15768030
[TBL] [Abstract][Full Text] [Related]
10. Proteome-wide discovery of unknown ATP-binding proteins and kinase inhibitor target proteins using an ATP probe.
Adachi J; Kishida M; Watanabe S; Hashimoto Y; Fukamizu K; Tomonaga T
J Proteome Res; 2014 Dec; 13(12):5461-70. PubMed ID: 25230287
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive identification of staurosporine-binding kinases in the hepatocyte cell line HepG2 using Capture Compound Mass Spectrometry (CCMS).
Fischer JJ; Graebner Baessler OY; Dalhoff C; Michaelis S; Schrey AK; Ungewiss J; Andrich K; Jeske D; Kroll F; Glinski M; Sefkow M; Dreger M; Koester H
J Proteome Res; 2010 Feb; 9(2):806-17. PubMed ID: 20028079
[TBL] [Abstract][Full Text] [Related]
12. Affinity Enrichment Chemoproteomics for Target Deconvolution and Selectivity Profiling.
Werner T; Steidel M; Eberl HC; Bantscheff M
Methods Mol Biol; 2021; 2228():237-252. PubMed ID: 33950495
[TBL] [Abstract][Full Text] [Related]
13. An immuno-chemo-proteomics method for drug target deconvolution.
Saxena C; Zhen E; Higgs RE; Hale JE
J Proteome Res; 2008 Aug; 7(8):3490-7. PubMed ID: 18590316
[TBL] [Abstract][Full Text] [Related]
14. Small molecule protein interaction profiling with functional protein microarrays.
Meng L; Mattoon D; Predki P
Methods Mol Biol; 2009; 572():177-88. PubMed ID: 20694692
[TBL] [Abstract][Full Text] [Related]
15. Compound immobilization and drug-affinity chromatography.
Rix U; Gridling M; Superti-Furga G
Methods Mol Biol; 2012; 803():25-38. PubMed ID: 22065216
[TBL] [Abstract][Full Text] [Related]
16. A new functional, chemical proteomics technology to identify purine nucleotide binding sites in complex proteomes.
Hanoulle X; Van Damme J; Staes A; Martens L; Goethals M; Vandekerckhove J; Gevaert K
J Proteome Res; 2006 Dec; 5(12):3438-45. PubMed ID: 17137346
[TBL] [Abstract][Full Text] [Related]
17. Identification of Yersinia pestis and Escherichia coli strains by whole cell and outer membrane protein extracts with mass spectrometry-based proteomics.
Jabbour RE; Wade MM; Deshpande SV; Stanford MF; Wick CH; Zulich AW; Snyder AP
J Proteome Res; 2010 Jul; 9(7):3647-55. PubMed ID: 20486690
[TBL] [Abstract][Full Text] [Related]
18. Chemical proteomics for drug discovery based on compound-immobilized affinity chromatography.
Katayama H; Oda Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):21-7. PubMed ID: 17241823
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the novel broad-spectrum kinase inhibitor CTx-0294885 as an affinity reagent for mass spectrometry-based kinome profiling.
Zhang L; Holmes IP; Hochgräfe F; Walker SR; Ali NA; Humphrey ES; Wu J; de Silva M; Kersten WJ; Connor T; Falk H; Allan L; Street IP; Bentley JD; Pilling PA; Monahan BJ; Peat TS; Daly RJ
J Proteome Res; 2013 Jul; 12(7):3104-16. PubMed ID: 23692254
[TBL] [Abstract][Full Text] [Related]
20. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
